Dermatology Devices Market Analysis & Forecast 2032

Devices used in dermatology are those that can be utilized during surgery, for treating skin conditions, or for diagnosing them. Dermatologists and surgeons can diagnose and treat skin conditions with the aid of dermatology devices. Various medical care facilities, including hospitals, dermatology clinics, doctor's offices, and university research institutions, use these devices. Global dermatology devices market is estimated to be valued at US$ 5,299.7 million in 2022 and is expected to exhibit a CAGR of 7.7 % during the forecast period (2022-2030).

Figure 1. Global Dermatology Devices Market Share (%), by Device type, 2022

To learn more about this report, Request sample copy

Increasing prevalence of skin diseases is expected to drive growth of the dermatology devices market.

Increasing prevalence of skin diseases is expected to drive growth of the dermatology devices market. For instance, according to the World Health Organization report 2018, skin diseases were among the most common of all human health afflictions and affected almost 900 million people in the world.

Figure 2. Global Dermatology Devices Market Share (%), by Region, 2022

To learn more about this report, Request sample copy

Increasing product launches by key players operating in the market are expected to drive the market growth during the forecast period.

Increasing product launches by key players operating in the market are expected to drive the market growth during the forecast period. For instance, in January 2019, Alma Lasers, which is provides medical aesthetic lasers & radiofrequency devices for surgical, medical and beauty providers, launched Soprano Titanium laser hair removal system.

Global Dermatology Devices Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, UAE, Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another.

The COVID-19 pandemic has had a negative impact on the expansion of the dermatology devices market. Due to the increase in COVID-19 cases, international supply chains for dermatology equipment were affected by global government measures like shutdown and strict rules. Dermatologists and surgeons use dermatological equipment to identify and treat skin conditions. In order to avoid disease transmission among patients, the dermatology division's closure and the cancellation of dermatological treatments during the pandemic had an influence on market for dermatology devices.

Global Dermatology Devices Market: Key Developments

In July 2019, Hologic’s Cynosure, which is a medical technology company, launched TempSure firm hand-piece on the TempSure platform and SculpSure, a non-surgical body contouring (lipolysis) treatment designed to permanently eliminate fat cells in problem areas.

In June 2019, Lumenis, Ltd., which provides minimally-invasive clinical solutions for the ophthalmology and aesthetic markets, entered into a distribution agreement with DELEO, which is a France-based company that designs and manufactures Medical Cryolipolysis and High Power Light-emitting diode (LED) devices for the aesthetic medicine sector, for distribution of its products in France.

Global Dermatology Devices Market: Restraint

High cost of dermatology treatment  is expected to hinder growth of the global dermatology devices market. For instance, according to the American Society of Plastic Surgeons (ASPS), the average cost of ablative laser skin resurfacing ranges from US$ 2,000 to US$ 25,000.

Key Players    

Valeant Pharmaceuticals International Inc., Lumenis, Ltd., Hologic, Inc., Syneron Candela Ltd., Avita Medical Ltd., Alma Lasers, Ltd., Lutronics Corporation, Beijing Toplaser Technology Co. Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., and Cutera, Inc.